In this review, we conducted a comprehensive search to evaluate the significance of the p38 signaling pathway in the pathogenesis of COPD and the efficacy of available p38 inhibitors for COPD treatment. The gene discussed is MAPK1; the disease is chronic obstructive pulmonary disease.